Although exposure to ultraviolet rays is a primary cause of skin cancer, factors such as your age, sex, and smoking habits also may contribute to developing this health issue.

Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster cancer drug Libtayo for certain ...

Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...

Kidman Park man, Joshua Giorgio died surrounded by family and friends on October 4 this year after a brave battle with oral ...

New safety and pharmacokinetic data from Phase 3 C-POST trial provide insights on an every 6-week dosing regimen of adjuvant Libtayo® (cemiplimab) in high-risk cutaneous squamous cell carcinoma ...

A new deep learning tool accurately predicts metastatic risk in cSCC, outperforming current clinicopathological and molecular ...

What started as a routine dental infection for Kempton Park resident Jaco Pretorius turned into a life-altering squamous cell carcinoma diagnosis.

The US FDA has granted breakthrough therapy designation (BTD) to the bifunctional antibody ficerafusp alfa (BCA101) in ...

Could a daily vitamin B3 pill prevent skin cancer? New research finds nicotinamide cuts recurrence risk by more than half in ...

The company is studying the mRNA tumor-associated antigen vaccine as a monotherapy and in combination with Keytruda.

Diane Keaton, known for her roles in films like ‘Annie Hall’ and ‘The Godfather,’ died on October 11 at the age of 79 ...

Shares of Bicara Therapeutics rose sharply in premarket trading Monday after the clinical-stage biopharmaceutical company won U.S. Food and Drug Administration breakthrough-therapy designation for its ...